Shark cartilage for cancer Journal Article
| Author: | Green, S. |
| Article Title: | Shark cartilage for cancer |
| Abstract: | Shark cartilage as a cancer therapy was first promoted by I. William Lane, PhD, in 1983. The theory that shark cartilage could be effective against cancer was based in the fact that cartilage contains anti-angiogenesis factors that inhibit new growth of blood vessels, and that new blood vessels facilitate reproduction of cells in solid tumors. However, anti-angiogenesis factors are proteins that are digested by stomach and pancreatic enzymes, and therefore cannot be absorbed whole by the intestinal tract. In addition, no consistent clinical effect of these factors has been demonstrated in human cancer. |
| Keywords: | platelet derived growth factor; unclassified drug; clinical trial; review; angiogenesis inhibitor; nonhuman; solid tumor; alpha interferon; protein; drug synthesis; angiogenesis; disease model; health care cost; cancer inhibition; octreotide; pancreas enzyme; kaposi sarcoma; thrombospondin 1; beta interferon; somatostatin derivative; stomach; fumagillol chloroacetylcarbamate; angiostatin; synthetic peptide; cartilage; herbimycin a; penicillamine; cyclodextrin derivative; digestion; shark; vapreotide; fumagillin; powder; cancer; human; angioinhibin; chitin derivative; colecalciferol derivative; glycylarginylglycylaspartylserine; steroid cyclodextrin; tetradecasulfate; tpn 470; intestine absorption |
| Journal Title: | Scientific Review of Alternative Medicine |
| Volume: | 7 |
| Issue: | 1 |
| ISSN: | 1095-0656 |
| Publisher: | Prometheus Books Inc. |
| Date Published: | 2003-01-01 |
| Start Page: | 21 |
| End Page: | 25 |
| Language: | English |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Export Date: 25 September 2014 -- Source: Scopus |
Related MSK Work